Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Whole Genome Sequence and Phylogenetic Analysis Show Helicobacter pylori Strains from Latin America Have Followed a Unique Evolution Pathway.

Muñoz-Ramírez ZY, Mendez-Tenorio A, Kato I, Bravo MM, Rizzato C, Thorell K, Torres R, Aviles-Jimenez F, Camorlinga M, Canzian F, Torres J.

Front Cell Infect Microbiol. 2017 Feb 28;7:50. doi: 10.3389/fcimb.2017.00050. eCollection 2017.

2.

Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.

Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, Passarelli B, Camorlinga M, Bouley DM, Alvarez G, Nusse R, Torres J, Amieva MR.

Gastroenterology. 2015 Jun;148(7):1392-404.e21. doi: 10.1053/j.gastro.2015.02.049. Epub 2015 Feb 26.

PMID:
25725293
3.

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer.

Ruhaak LR, Barkauskas DA, Torres J, Cooke CL, Wu LD, Stroble C, Ozcan S, Williams CC, Camorlinga M, Rocke DM, Lebrilla CB, Solnick JV.

EuPA Open Proteom. 2015 Mar 1;6:1-9.

4.

[Association of interleukin-1 genetic polymorphism and CagA positive Helicobacter pylori with gastric cancer in Colombia].

Martínez T, Hernández-Suárez G, Bravo MM, Trujillo E, Quiroga A, Albis R, Robayo JC, Bravo JC, Camorlinga M.

Rev Med Chil. 2011 Oct;139(10):1313-21. doi: /S0034-98872011001000010. Epub 2012 Jan 3. Spanish.

5.

Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer.

Ayala G, Flores-Luna L, Hernández-Amaro D, Mendoza-Hernández G, Chihu-Amparán L, Bernal-Sahagún F, Camorlinga M, Lazcano-Ponce E, Torres J.

Cancer Causes Control. 2011 Oct;22(10):1425-34. doi: 10.1007/s10552-011-9817-5. Epub 2011 Jul 21.

PMID:
21779758
6.

Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer.

Partida-Rodríguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramírez M, Lazcano E, Perez-Rodríguez M.

Int J Cancer. 2010 Apr 15;126(8):1861-1868. doi: 10.1002/ijc.24773.

7.

Immune and proliferative cellular responses to Helicobacter pylori infection in the gastric mucosa of Mexican children.

Muñoz L, Camorlinga M, Hernández R, Giono S, Ramón G, Muñoz O, Torres J.

Helicobacter. 2007 Jun;12(3):224-30.

PMID:
17493002
8.

[Importance of IgG anti-CagA antibodies of Helicobacter pylori in Venezuelan patients with gastric diseases].

Perrone M, Muñoz L, Camorlinga M, Correnti M, Cavazza ME, Lecuna V, Torres J.

Invest Clin. 2005 Dec;46(4):357-67. Spanish.

PMID:
16353543
9.

Trends in Helicobacter pylori infection and gastric cancer in Mexico.

Torres J, Lopez L, Lazcano E, Camorlinga M, Flores L, Muñoz O.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1874-7. Review. No abstract available.

10.

Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice.

Takata T, El-Omar E, Camorlinga M, Thompson SA, Minohara Y, Ernst PB, Blaser MJ.

Infect Immun. 2002 Jun;70(6):3073-9.

12.

Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses.

Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, Tham KT, Camorlinga M, Blaser MJ, Falkow S, Peek RM Jr.

J Clin Invest. 2001 Mar;107(5):611-20.

13.

[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer].

Dehesa M, Larisch J, Dibildox M, Vega B, Di Silvio M, Rodríguez L, Camorlinga M, Almaguer I, Ramírez-Barba E, Torres J.

Rev Gastroenterol Mex. 1998 Apr-Jun;63(2):66-71. Spanish.

PMID:
10068730
14.

Hospital-acquired diarrhea in adults: a prospective case-controlled study in Mexico.

Zaidi M, Ponce de León S, Ortiz RM, Ponce de León S, Calva JJ, Ruiz-Palacios G, Camorlinga M, Cervantes LE, Ojeda F.

Infect Control Hosp Epidemiol. 1991 Jun;12(6):349-55.

PMID:
1906497
15.

Colonization by Clostridium difficile in hospitalized children: risk factors and typification of the isolated strains.

Camorlinga M, Muñoz O, Guiscafré H, Torres J.

Arch Invest Med (Mex). 1991 Jan-Mar;22(1):19-26.

PMID:
1819972
16.

Neutralization of cytotoxic activity of Clostridium difficile with fecal flora.

Torres JF, Camorlinga M, Muñoz O.

Arch Invest Med (Mex). 1987 Oct-Dec;18(4):315-7. No abstract available.

PMID:
3453624
17.

Inhibitory activity of fecal flora against the multiplication of Clostridium difficile.

Torres JF, Camorlinga M, Muñoz O.

Arch Invest Med (Mex). 1986 Apr-Jun;17(2):147-56. English, Spanish. No abstract available.

PMID:
3296983

Supplemental Content

Loading ...
Support Center